# Currently, the analyst consensus on Hansoh Pharmaceutical Group Company Limited is a Strong Buy with an average price target of HK$46.14.

*biotech · news · 2026-04-22 · Markets Insider*

## Key points

- Morgan Stanley set a new price target of HK$45.00 for Hansoh Pharmaceutical shares.
- Hansoh Pharmaceutical shares last closed at HK$39.90, below the new price target.
- The analyst consensus rates Hansoh Pharmaceutical Group as a Strong Buy with a HK$46.14 target.
- Hansoh reported Q2 revenue of HK$7.43 billion and net profit of HK$3.13 billion, both up year-over-year.

**Companies:** Hansoh Pharmaceutical Group Company Limited

[Read the full story on Markets Insider](https://markets.businessinsider.com/news/stocks/morgan-stanley-sticks-to-its-buy-rating-for-hansoh-pharmaceutical-group-company-limited-3692-1036047314)

---

Canonical: https://newsio.io/n/a84e0528-3c54-406e-9140-e7e78f4674c2/currently-the-analyst-consensus-on-hansoh-pharmaceutical-group-company-limited-i
Summarized by Newsio from Markets Insider. https://newsio.io/how-it-works